Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class ASSE: 600436

Announcement on Completion of 1st Subject Enrollment in Phase II Clinical Trials of Wenfei Dingchuan Capsules

· Issued by Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Completion of 1st Subject Enrollment in Phase II Clinical Trials of Wenfei Dingchuan Capsules

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis